Metabolomics holds the promise as a new technology to diagnose highly heterogeneous diseases.
111 Activation value of the hidden layer (y) can be calculated by sigmoid of the multiplication of the input 112 sample x with the weight matrix W and bias b. The transpose of the weight matrix W and the bias b can 113 then be used to construct the output (z) layer, as described in equation (3) .
115
The best set of the weight matrix W and bias b are expected to minimize the difference between the input 116 layer (x) and the output layer (z). The objective function is called cross-entropy in equation (4) below, in 117 which the optimal parameters are obtained by stochastic gradient descent searching. overall performance of the models. To avoid sampling bias, we repeated the above splitting process ten 139 times and calculated the average AUC on the hold out 10 test samples. To control overfitting, we used two 140 regularization parameters: L1, which increases model stability and causes many weights to become 0 and 141 L2, which prevents weights enlargement.
142
We tuned DL model and other machine learning algorithms, on the following parameters: DL model:
143
Epochs (number of passes of the full training set), l1 (penalty to converge many weights to 0) and l2 (penalty 144 to prevent weights enlargement), and input dropout ratio (ratio of ignored neurons in the input layer during 
201
DL as other machine learning algorithm needs more samples to achieve high accuracy 39 . To assess the 202 effect of sample size on various models, we randomly removed ¼, ½, and ¾ of the data sets (Figure S1).
203
As expected, decreasing in sample size decreases the averaged AUCs of all classification methods in 204 general except LDA on ¼ samples, due to overfitting. Notably, the reduction of average AUC in DL is most 205 pronounced among all methods, from the full to ¾ data set ( Figure S1 ). While DL loses the best average 206 AUC status when the sample size is around 255, GBM, SVM and RF have the highest AUC for small 207 sample sizes of 203, 136 and 68, respectively. Similarly, we also experimented the effect of metabolite size 208 on various models (Figure S2 ). We randomly removed ⅛, ¼, and ½ of the 162 metabolites. Even with 209 reduced numbers of metabolites, deep learning and the robust machine learning method SVM still have 210 fairly good predictions, compared to other algorithms tested. This suggests that, due to colinearality, much of information still exist in the remaining metabolites. Together, the drop-out experiments (Figures S1 and 212 S2) demonstrate that DL method is sensitive to sample size, but much less sensitive to metabolite size.
213

Important features from DL
214
To relate the importance of metabolites to ER status directly, we ranked the metabolites extracted from DL 215 model based on their functional contributions to the outputs. In this approach, features that provide unique 216 information to the trained network are ranked more importantly than those giving redundant information 40 .
217
We listed the top 20 metabolites from DL in Table S1 , and presented their heatmap and boxplots in 
222
Among the 20 features, the top five features are beta-alanine, xanthine, isoleucine, glutamate, and taurine.
223
These five metabolites have been either proposed as breast cancer biomarkers or associated with breast 224 cancers in the original metabolomics report 19 and/or other studies 6 
231
They found isoleucine had significant differential level between ER+ (lower) and ER-(higher) samples.
232
Similarly, a study among female breast cancer patients (n=50) suggested serum taurine as an early marker,
233
where its level was significantly lower than the normal (n=20) and high risk samples (n=15) 42 (Figure 2B) . Twelve metabolites are shared between DL and one or more algorithms.
239
Among them, 1 (xanthine) is shared by six methods, 2 ( glyceric acid and citrulline) are shared by five 240 methods, 4 (glutamine, taurine, glutamine acid, and beta-alanine) are shared by four methods, 1 (2-241 aminoadipic acid) is shared by three methods, 2 (nicotinamide acid and trehalose) are shared by two 242 methods, and two (linoleic acid and hypoxanthine) are shared by one method (Table S1 ). Additionally, DL are associated with the ER+ status ( Figure 3A) . These results confirm that the nodes in DL have significant 250 biological meaning.
251
We identified a total of 129 metabolites which contribute most to the activation values of the top 12 nodes.
252
Their relationships between the 129 metabolites and 12 nodes are shown in Figure S4 . We define that to be associated with breast cancer, but not between ER+ and ER-cancers 44 . Uracil is, however, a potencial 261 new marker for ER-breast cancer that was not reported previously, according to our knowledge.
262
To link the metabolites in Figure S4 with biological functions, we conducted pathways enrichment analysis 
272
All these five metabolites were found related with breast cancer previously 47-49 .
273
Integration of DL metabolites and enzymes 274
We further aimed to validate the important metabolite features of DL model, by integrating metabolomics 
287
To gain insights at individual metabolite/enzyme level, we then calculated Spearman correlations between 288 the intensity levels of the top 20 metabolites and enzymes whose gene expression levels are significantly 289 different between ER+/ER-for the same patients 20 . The Circos plot in Figure 5 shows the names of 
296
Complementary to the correlation based analysis, we also used Metscape (Cytoscape plug-in) for gene-297 metabolite network analysis, by combining the ER+/ER-metabolomics data 18 and gene expression (from 298 GSE59198) 20 for the same patients. ABAT, the enzyme that catalyze beta-alanine to malonate 299 semialdehyde ( Figure 6B ), is highly correlated with beta-alanine (r=-0.62, Figure 6A ). To understand better 300 the connection between beta-alanine and FOX genes family, we performed motif enrichment analysis for 301 the enzymes interacted with beta-alanine in Figure 6B 
312
There are many advantages of DL over shallow machine learning algorithms, which are beyond the scope 
319
Therefore, DL succeeds to construct high-level transformed features from input data, making it more 320 desirable than shallow machine learning algorithms in this respect 14 .
321
We demonstrated that DL has a higher predictive accuracy over the other six popular machine learning 322 methods, in detecting ER status from metabolomics data. DL exploits the idea that the higher "succeeding" 323 layer is learned from the lower "preceding" layer and selects the essential metabolites from DL model.
324
These metabolites are useful for the learning process and explain the high predictability of DL compared 325 to conventional machine learning algorithms. DL extracted features that could be considered as novel 326 biomarkers, such as uracil, which were not previously reported as breast cancer. Also, unlike other machine 327 learning methods, DL method offers additional insights on eight KEGG pathway being significantly 328 different due to ER status. All these new observations warrant further investigation.
329
An interesting new link we discover lies between FOXM1 family and beta-alanine. A recent study showed 330 FOXM1 to be a major cause for resistance to various chemotherapeutics 53 , and reduction of FOXM1 levels 331 induced apoptosis of breast cancer cells 54 . The motif enrichment analysis of the beta-alanine interacted 332 enzymes indicates that the transcription factor FOXO1 targeted the promoter regions of these enzymes.
333
Thus the relationships among beta-alanine, FOXM1 and FOXO1 is worth further investigation. In addition,
334
we found many interesting involvement of DL unique metabolites in breast cancer diagnosis and treatment.
335
For example, phenylalanine is found significantly elevated in the advanced metastatic breast cancer 55 and 336 linoleic acid has been used to lower the risk of breast cancer 56 . Also, Putrescine has been known to play a 337 critical role in many metabolomics processes in breast cancer, such as apoptosis, and proliferation 57 
342
Despite the outstanding performance of DL methods, one should be mindful of several caveats in its 343 application in metabolomics research. DL is time-consuming computation ( 
353
Lastly, in this report we compared the ML vs DL under the topic of classification of metabolomics data.
354
The advantages of DL on other non-classification problems in metabolomics research are yet to be explored.
355
For example, unsupervised machine learning algorithms such as PCA and hierarchical clustering were 356 applied to the metabolomics data 60 , and our group is currently exploring using autoencoders for 357 unsupervised learning in metabolomics data. As another example, we have also worked on prognosis 358 prediction using shallow and deep neural network models in the genomics space 61 
